Moreover, HCMV seropositive MS patients displayed not only an altered B-cell phenotype and function, but also a modulation of the IFNβ response and a reduced pro-inflammatory cytokine B-cell profile, indicating a putative protective role of HCMV [98]. This evidence concerns the gene IFNB1 and myeloid sarcoma.